Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
May 16 2022 - 9:32AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR
15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the
month of May 2022
Commission
File Number 001-15170
GlaxoSmithKline plc
(Translation
of registrant's name into English)
980 Great West Road, Brentford, Middlesex, TW8 9GS
(Address
of principal executive office)
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form
20-F . . . .X. . . . Form 40-F . . . . . . . .
Indicate
by check mark if the registrant is submitting the Form 6-K in paper
as permitted by Regulation S-T Rule 101(b)(1): ____
Indicate
by check mark if the registrant is submitting the Form 6-K in paper
as permitted by Regulation S-T Rule 101(b)(7): ____
GSK plc
(the 'Company')
Change of name to GSK plc
The Company today confirms its name has changed from
GlaxoSmithKline plc to GSK plc.
The Company announced the decision to change its name to GSK plc on
27 April 2022 together with its first quarter 2022 results. This
change has now taken effect.
The London Stock Exchange and the New York Stock Exchange will
reflect the change of name in due course.
Shareholders should note that their shareholdings will be
unaffected by the change of name. Existing share certificates
should be retained as they will remain valid for all purposes and
no new share certificates will be issued.
The ISINs, SEDOLs, CUSIPs and ticker symbols of the Company's
ordinary shares and ADS remain unchanged. The Company's Legal
Entity Identifier (LEI) remains 5493000HZTVUYLO1D793.
V A Whyte
Company
Secretary
16 May 2022
SIGNATURES
|
|
GlaxoSmithKline plc
|
|
|
(Registrant)
|
|
|
|
|
Date: May
16, 2022
|
|
|
|
|
|
|
By:/s/ VICTORIA
WHYTE
--------------------------
|
|
|
|
|
|
Victoria Whyte
|
|
|
Authorised
Signatory for and on
|
|
|
behalf
of GlaxoSmithKline plc
|
GSK (NYSE:GSK)
Historical Stock Chart
From Jun 2024 to Jul 2024
GSK (NYSE:GSK)
Historical Stock Chart
From Jul 2023 to Jul 2024
